Skip to main content
At-the-market program for stock offering announced by Chembio

An at-the-market program has been established by Chembio Diagnostics through which it may occasionally offer up to $21.2 million worth of its common stock. The company plans to use net proceeds from the program as working capital, as well as for investments in business operations and possible acquisitions.

Full Story: